What is aspartimide formation?

A side reaction where the backbone amide following an aspartate attacks its side chain, forming a five-membered succinimide ring that can reopen incorrectly.

Why can't mass spectrometry detect the impurity?

The isoaspartyl product has the identical formula and mass — a bond moved, nothing was added or lost.

Which sequences are most at risk?

It is sequence-dependent, with small unhindered residues after the aspartate favouring it. Asp-Ala is a documented susceptible motif.

Peptide Reference

Aspartimide Formation and Why It Hides

JMWritten & reviewed by Jack Muncaster · Founder, UK PeptidesLast reviewed 2026-08-233 cited sources

Aspartimide formation is a sequence-dependent side reaction in solid-phase synthesis of peptides containing aspartate. The backbone amide attacks the aspartate side chain to form a five-membered ring, which then opens to give products including isoaspartyl peptides of identical mass.

Key facts

Affects: Peptides containing aspartate
Sequence-dependent: Yes — Asp-Ala is a documented motif
Catalysed by: Acid or base
Mechanism: Adjacent amide attacks the side chain
Ring formed: Five-membered succinimide
Key product: Isoaspartyl peptide — same mass
Also occurs in: Formulations, not only synthesis

What actually happens

The nitrogen of the peptide bond immediately following an aspartate residue attacks the carbonyl of that aspartate's side chain. That closes a five-membered ring — the aspartimide, a succinimide. Ruczyński and colleagues described it in the Journal of Peptide Science in 2008 as one of the most serious side reactions in solid-phase synthesis of aspartate-containing peptides, and both acid and base catalyse it.

Why the ring reopening is the real problem

The aspartimide is unstable and opens again, but it can open two ways. One restores the original aspartate linkage. The other produces an isoaspartyl peptide, where the chain now runs through the side-chain carboxyl instead of the backbone one — the same atoms in a different connectivity. Cao and colleagues reported in Biochemistry in 2023 that hydrolysis proceeds regioselectively above pH 7, so conditions determine which way it resolves.

Research material referenced

BPC-157 5mg — third-party HPLC tested

View — £15.99

Why mass spectrometry cannot see it

An isoaspartyl peptide has the identical molecular formula and therefore the identical mass. Nothing was added and nothing was lost — a bond simply moved. A mass spectrum of a preparation substantially converted to isoaspartate looks exactly like a mass spectrum of the intended compound, which is why this impurity survives the check most certificates lead with.

Why it is sequence-dependent

The reaction needs the adjacent backbone nitrogen to reach the side-chain carbonyl, so what follows the aspartate governs how readily it happens. Small, unhindered residues make the approach easy. Ruczyński's work modelled the Asp-Ala motif specifically for this reason, and susceptibility varies substantially with the neighbouring residue.

Which compounds in this catalogue carry the motif

Both aspartate-containing peptides here. BPC-157 is Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, which places an Asp-Ala pairing in the middle of the sequence. DSIP is Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu, with the same Asp-Ala pairing. Neither is an unusual sequence, and neither product listing mentions the susceptibility.

That it is not only a synthesis problem

Cao and colleagues describe aspartimides as undesired side products in solid-phase synthesis and in pharmaceutical formulations. The chemistry does not stop when synthesis finishes — it can proceed slowly in a stored preparation, which makes it a stability consideration as well as a manufacturing one, and it is pH-sensitive in both settings.

Extended research context

The Peptide Reference deep dive

Deep dive: what 'peptide' actually means

A peptide is a short chain of amino acids linked by peptide bonds, typically 2–50 residues. Above that boundary the molecule is usually called a protein. Peptides can be endogenous (produced by the body) or synthetic (manufactured by solid-phase peptide synthesis, SPPS). The 'research peptide' category refers specifically to synthetic peptides supplied for laboratory use — not medicines, not supplements.

Why HPLC and mass spec together

HPLC (High-Performance Liquid Chromatography) reports the purity of a batch by measuring what percentage of the sample matches the target peptide's retention time. Mass spectrometry independently confirms the target's molecular weight. Together they answer two different questions: 'is it clean?' and 'is it the right molecule?'. A CoA that reports only one is incomplete.

How to read a Certificate of Analysis

A complete peptide CoA lists: batch number, HPLC purity (area %), mass-spec measured mass vs theoretical, water content (Karl Fischer), acetate/counterion content, appearance, and often endotoxin and residual solvents. Learn to spot the missing fields — that's usually where quality claims fall apart.

Research applications

▸Reference standards for analytical method development
▸Comparator peptides in receptor-binding assays
▸Stability testing of lyophilised material
▸Formulation R&D for topical and aqueous carriers
▸Teaching material for peptide chemistry courses

Handling checklist

✓Confirm HPLC ≥98% and mass-spec identity on CoA
✓Store lyophilised at −20 °C long-term
✓Reconstitute with bacteriostatic or sterile water only
✓Aliquot to minimise freeze/thaw cycles
✓Label vials with date, concentration, and batch

Common research-handling mistakes

Learnt from thousands of researcher orders across our UK labs.

✗ Buying a peptide without a CoA

Fix: Insist on an in-batch HPLC + mass-spec certificate before purchase.

✗ Using DI water for reconstitution

Fix: Use bacteriostatic (0.9% benzyl alcohol) or sterile water only.

✗ Storing lyophilised vials at room temperature long-term

Fix: Freeze at −20 °C; short-term 2–8 °C is acceptable for weeks, not months.

Continue researching

Peer-reviewed guides, comparators and matched reference materials.

Frequently asked questions

What is aspartimide formation?: A side reaction where the backbone amide following an aspartate attacks its side chain, forming a five-membered succinimide ring that can reopen incorrectly.
Why can't mass spectrometry detect the impurity?: The isoaspartyl product has the identical formula and mass — a bond moved, nothing was added or lost.
Which sequences are most at risk?: It is sequence-dependent, with small unhindered residues after the aspartate favouring it. Asp-Ala is a documented susceptible motif.

Primary sources & clinical trials

Peer-reviewed research and registered trials from PubMed, ClinicalTrials.gov, PubChem, FDA and NIH. All links open in a new tab and point to the primary source, so every claim can be verified at origin.

Written and reviewed by

Jack Muncaster · Founder, UK Peptides

Jack founded UK Peptides in Manchester after repeatedly receiving research compounds with missing or recycled paperwork. He is responsible for supplier selection, batch release decisions and the content published in this research library. Every article here is sourced to primary literature and every product page to a signed third-party certificate.

How we write and check this content Report a factual error in this article

Popular across the research hub

One flagship guide from every other research category — keep exploring.

← Back to Forum